Realizing the potential of agonistic antibody immunotherapy

Ask HN: What is the latest on treatment of Metastatic Breast Cancer?

Engineered immunotherapy drug eliminates aggressive metastatic cancers in clinical trial

Researchers at Rockefeller University have developed an engineered CD40 agonist antibody that successfully eliminated aggressive metastatic

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

AI-Driven Protein Binder Design: Progress and Pitfalls in Evaluation Practices

This article discusses the rapid advancement of de novo protein binder design using AI, including antibodies and nanobodies. While the field

10 out of 12 people cured in Type 1 Diabetes Study

Acute versus Long-term anti-GPVI Treatment: From Receptor Blockade to Partial Downregulation